XML 120 R112.htm IDEA: XBRL DOCUMENT v3.22.0.1
Product and Geographic Sales Information - Adjusted EBITDA by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Total Adjusted EBITDA $ 164,833 $ 78,222  
Benefit (provision) for income taxes (263) (14,753)  
Depreciation and amortization (131,654) (51,441)  
Interest, net (37,393) (30,940)  
Transition services agreement costs 0 (1,551)  
Transition, transformation and integration expense (46) (2,228)  
Deferred revenues adjustment (3,024) (1,882)  
Transaction related costs 22,924 (26,689)  
Share-based compensation expense (39,020) (17,469)  
Restructuring and impairment (67,895) (7,754)  
Impairment of Long-Lived Assets to be Disposed of     $ 18,431
Other (15,628) 2,484  
Net income attributable to Clarivate (55,951) (129,633)  
Fair Value Adjustment of Warrants 51,215 (55,632)  
Science Segment      
Segment Reporting Information [Line Items]      
Total Adjusted EBITDA 90,594 63,954  
Intellectual Property Segment (As Restated)      
Segment Reporting Information [Line Items]      
Total Adjusted EBITDA $ 74,239 $ 14,268